September 20, 2025 - 23:29

In a significant policy shift, the U.S. government is set to impose a hefty annual fee of $100,000 for H-1B visa applications, a move that is anticipated to have profound implications for the technology sector. This decision comes at a time when the number of foreign workers in science, technology, engineering, and mathematics (STEM) fields has surged, more than doubling from 2000 to 2019, reaching nearly 2.5 million.
The H-1B visa program has long been a vital pathway for skilled international workers to contribute to the U.S. economy, particularly in tech hubs where there is a high demand for specialized talent. Critics argue that the new fee will deter many companies from hiring foreign workers, potentially leading to a talent shortage in key industries. Proponents of the fee believe it could help fund domestic workforce development initiatives. As the tech landscape evolves, the implications of this policy change will be closely monitored by industry leaders and policymakers alike.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...